Here’s How the Other Major Insulin Makers Are Responding After Eli Lilly’s Price Cap

Health policy experts say Eli Lilly’s competitors—Sanofi, which makes Apidra and Lantus, and Novo Nordisk, which makes NovoLog and Levemir—are now facing increasing pressure to respond…
Read More

About The Author

Jonathan Jeriah

See author's posts